Gelteq (GELS) Net Cash Flow Growth (1y) (2024 - 2025)

Gelteq (GELS) Net Cash Flow Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Haleon 89.19 Bn 87.33 Bn - -
2 Teva Pharmaceutical Industries 35.86 Bn 32.12 Bn 1.97 Bn 112.26%
3 Zoetis 32.52 Bn 30.58 Bn 1.62 Bn -44.11%
4 Takeda Pharmaceutical 27.52 Bn 23.46 Bn 4.39 Bn 209.30%
5 United Therapeutics 23.22 Bn 21.07 Bn 648.10 Mn -236.85%
6 RedHill Biopharma 21.76 Bn 21.76 Bn - -
7 Viatris 20.29 Bn 18.48 Bn 1.16 Bn 13,485.29%
8 Neurocrine Biosciences 17.72 Bn 16.40 Bn 800.70 Mn -1,047.81%
9 Elanco Animal Health 12.59 Bn 12.16 Bn 785.00 Mn -1,020.00%
10 Gelteq 681.60 -47,880.04 - 70.62%

Historic Data

Download Data
DateValue
Dec 31, 2025 70.62%
Dec 31, 2024 -674.01%